1[1]Sureda A,Carcia Frade LJ,Torrado MC,et al.A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia[J].Acta Haematol,1992,88(2,3):100-104.
2[2]Mamiya S,Itoh T,Endo Y,et al.Abnormal blood coagulation and fibrinolysis in chronic myeloproliferative disaorders[J].Rinsho Ketsueki,1991,32(5):527-536.
3[3]Guglielmi C,Martelli MP,Diverio D,et al.Clinical and biological relevance of immunophenotype in acute promyelocytic leukemia[J].Br J Haematol 1998,102:1035-1041.
4[4]Frankel SR,Eardley A,HellerG,et al.All – trans retinoic acid for acute promyelocytic leukemia:results of the New York study[J].Ann Intern Med,1994,120:278.
5[5]Wang SJ,Wang JZ.Atlas of Current Hemocytology,2001,370-372.
6[6]Colomb HM.Partial deletion of long ARM of chromosome M[J].Arch Internmed,1976,136:825.
7[7]Chen Z,Brand N,Chen A,et al.Fusion between a novel Krupple like zinc finger gene and the retnoic acid receptor α locus due to a variant t(11;17)translocation associated with acute promyelocytic leukemia[J].EMBO J,1993,12:1161-1167.
8[8]Grimwade D,Biondi A,Mozziconacci MJ,et al.Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17):results of the European Working Party[J].Blood,2000,96:1297-1308.
4Sanz MA.Treatment of acute promyelocytic leukemia[J].Hematology Am Soc Hematol Educ Program,2006:147-155.
5Shen ZX,Shi ZZ,Fang J,et a1.ALL-trans retinoic acid/As203combination yields a high quality remission and survival in newly diagnosed acute promylocytic Leukemia[J].Proc Natl Acad Sci USA,2004,101(15):5328-5335.
6Kastner P,Lawrence HJ,waltzinger C,et al.Positive and negative regulation of granulopoiesis by endogenous RARa[J].Blood,2001,97(5):1314-1320.
7Duprez E.A new role for C/EBP beta in acute promyelocytic leukemia[J].Cell Cycle,2004,3(4):389-390.
8Sanz MA,Lo Coco F,Martin G,et a1.Definition of replase risk and role of nonanthracycline drugs for consolidation in patients with acute promylocytic leukemia;a joint study of the PETHEMA and GIMEMA cooperative groups[J].Blood,2000,96(4):1247-1253.
